Send us a text

Elections were held this week and yielded some promising results for cannabis in several states. Another state joined the list of those that have legalized cannabis for adult-use, while others approved medical cannabis and cannabis decriminalization. This is a positive step for the progress of cannabis reform in the United States. Although this week’s elections had some great news for cannabis supporters, there is still a lot of work to be done. Also, Congress considers the economic benefit of federal legalization and other top headlines of the week are covered. Tune in to Cannabis Legalization News to stay up-to-date on the latest developments. 🍁🌱🔥🌬️🍃🌳🌞🚬 Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #CannabisCommunity #420 #CannabisCulture #Weed #CannabisLovers #CannabisDaily #CannabisLife #StayHigh #Budtenders #MedicalMarijuana #Hemp #Dab #Weedstagram #HighTimes #WeedLovers #Sativa #Indica #CBD

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

The HHS Letter, issued August 29th 2023, rescheduled cannabis from a Schedule I drug to a Schedule III drug. This move has been widely praised by members of the medical and scientific communities, as it paves the way for further research into the potential medicinal benefits of cannabis. Additionally, it reduces the stigma associated with cannabis use and possession, making it easier for people to access and use medical marijuana products without fear of criminal charges. Ultimately, the HHS Letter is a landmark ruling that shows progress towards more sensible regulations on marijuana and opens up new opportunities for research in this field. It may also become part of a larger trend towards decriminalizing or legalizing recreational marijuana in certain states or at the federal level - something many advocates have long advocated for. Plus more of the top stories of the week with Tom Howard and Miggy 420. #MedicalMarijuana #EndCannabisProhibition #CannabisLegalization #HHSLetter #CannabisAdvocacy Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz)

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

New research from the Federal Reserve Bank finds that states with legal marijuana see a significant economic boost, but also experience an increase in social costs. The report found that states that legalized marijuana for adults saw moderate economic gains after the policy change was implemented, with the number of jobs directly in the marijuana industry growing from less than 125,000 to more than 425,000 between 2017 and 2022. However, the report also found that states with legal marijuana saw an increase in social costs, including substance use disorders, chronic homelessness, and arrests.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

Cannabis News for October 15 2023 | Tom & Miggy on the Road This week Tom & Miggy are on the road and cover new federal workplace guidelines for THC testing do not create any new laws. Rather, they clarify that medical marijuana use is not a protected activity under federal law, and that employers are still able to fire employees for testing positive for THC, even if they have a medical marijuana card.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

Cannabis Legalization News for October 2023 The House of Representative had quite the shake-up this week leaving many to wonder how that will impact cannabis policy with the recent proposal by the HHS to reschedule cannabis and efforts to pass the SAFER Banking Act. Currently, marijuana is federally illegal, but legal in some states for medical and/or recreational use. This creates a problem for marijuana businesses, which have difficulty accessing banking services. Federal law prohibits banks from doing business with businesses that are involved in illegal activities. There is bipartisan support for legislation that would allow marijuana businesses to access banking services, but it has not yet been passed. Some Republicans have expressed opposition to the legislation, arguing that it would give legitimacy to an illegal industry. If a new House Speaker is elected who is more supportive of marijuana reform, it could increase the chances of legislation passing that would allow marijuana businesses to access banking services. This would be a major win for the marijuana industry and would make it easier for businesses to operate and grow. a lawsuit that has been filed against the US Department of Health and Human Services (HHS) to compel the release of a letter that the Biden administration sent to the Drug Enforcement Administration (DEA) recommending that marijuana be rescheduled. The letter has not been released publicly, but it is believed to contain the Biden administration's reasoning for why marijuana should be rescheduled and what the DEA should do next. The lawsuit was filed by attorney Matthew Zorn, who argues that the letter is a public record and that HHS is required to release it. The lawsuit also claims that HHS is withholding the letter in order to delay or prevent the DEA from rescheduling marijuana. The DEA currently classifies marijuana as a Schedule I drug, which means that it has a high potential for abuse and no currently accepted medical use. Rescheduling marijuana would make it easier for researchers to study the plant and for patients to access it for medical purposes. The outcome of the lawsuit is uncertain, but it could have a significant impact on the future of marijuana reform in the United States. If the court orders HHS to release the letter, it could put pressure on the DEA to reschedule marijuana. This week we also have news out of Arizona, Illinois, Ohio, New York, and Michigan. We also have guest Matt White joining us. Matt white is the creator behind the Strain Show, the Youtube channel where you can learn everything you ever wanted to know about cannabis. Don't miss this latest episode of Cannabis Legalization News. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabisindustry #cannabislegalization

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

The SAFER Act in the Senate | Easy DOT Physicals Dr.Nuesse The Senate Banking Committee voted 14-9 on Wednesday to advance the Secure and Fair Enforcement Regulation (SAFER) Banking Act. This is the first time that a Senate committee has approved a marijuana banking bill, and it is a significant step forward for the cannabis industry. The SAFER Banking Act would allow banks to work with state-legal cannabis businesses without fear of federal penalties. This would provide a number of benefits to the cannabis industry, including: Reduced risk of crime and violence: Cannabis businesses would be able to use banks to deposit and withdraw money, which would reduce the need to keep large amounts of cash on hand. This would make them less of a target for criminals. Increased access to capital: Cannabis businesses would be able to apply for loans and lines of credit from banks, which would help them to grow and expand their operations. Reduced costs: Cannabis businesses would no longer have to pay high fees to use money services businesses (MSBs) to process their financial transactions. The passage of the SAFER Banking Act by the Senate Banking Committee is a positive sign for the cannabis industry. However, it is important to note that the bill still needs to be passed by the full Senate and House of Representatives before it can become law. It is also unclear when the bill will be considered by the full Senate. In the meantime, cannabis businesses will continue to face challenges in accessing banking services. However, the passage of the SAFER Banking Act by the Senate Banking Committee is a sign that progress is being made towards addressing this issue. This week we have guest speaker Dr. Matthew Nuesse joining us. Dr. Nuesse is a Certified Medical Examiner with nearly a decade of experience in drug testing and pre-employment medical examinations. He runs the largest YouTube channel specifically focused on federal drug testing. He co-founded the drug testing education course Exploroacademy.com. We have an all new Name That Strain and other titillating news stories from the week on Cannabis Legalization News. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

Federal Cannabis Legalization News | Safter Banking Act Update This week we saw a major push by Senate Majority Leader Chuck Schumer to legalize cannabis at the federal level when he circulated a petition, asking for signatures from supporters. These types of email campaigns are often used to build up their own email lists for political fundraising; however, Schumer has been an outspoken proponent of allowing banks to do business in the cannabis industry. On Wednesday, Schumer and a bipartisan group of cannabis supporters introduced a revised version of the SAFE Banking Act called the SAFER Banking Act. This updated version has some new provisions and is set for mark-up in the Senate next week. Meanwhile, two republican supporters of the SAFER Banking Act introduced their own bill to impede the proposition of rescheduling cannabis to a less regulated class. The DEA Act, as it’s known, would require congressional approval to propose a change to any federal drug law, adding another hurdle to the prospect of cannabis legalization if it were to pass both chambers of Congress. The MORE Act was also refiled again this week, making its way to the House for a third time. The bill is solely sponsored by Democrats and faces an uphill battle to make it through while the House is under GOP majority. New York continues to make headlines for their calamitous roll out of the adult-use industry in the state. Leafly, Ron DeSantis, and the NCAA also get some of the spotlight this week. Tune in to hear all about it. This is Cannabis Legalization News for the week of September 18th. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabis #cannabislegalization

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

Federal rescheduling of cannabis has been a big topic in recent news. A government analysis predicts the DEA is likely to reschedule cannabis. The analysis, conducted by the Congressional Research Service (CRS), is based on the DEA's past practices and the HHS's recent recommendation to reschedule marijuana. The CRS analysis states that the DEA has historically been reluctant to reschedule marijuana, but that it has also shown a willingness to do so when there is strong scientific evidence to support the change. In this case, the HHS's recommendation is based on a comprehensive review of the scientific literature, which found that there is sufficient evidence to support the medical use of marijuana. The CRS analysis also notes that the DEA is currently facing a number of challenges, including budget cuts and increasing public pressure to reform its drug scheduling system. These factors could make the DEA more likely to reschedule marijuana, as it would be a way to show that the agency is responsive to public concerns. However, it is important to note that the CRS analysis is just a prediction. The DEA is not required to follow the HHS's recommendation, and it could ultimately decide to keep marijuana in Schedule I. The DEA is expected to make a decision on the scheduling of marijuana in the coming months. If the DEA does decide to reschedule marijuana, it would be a major victory for advocates of cannabis reform. It would make it easier for researchers to study the potential medical benefits of marijuana, and it would make it easier for doctors to prescribe marijuana to patients with certain conditions. It would also make it possible for banks to offer services to marijuana businesses, which would help to legitimize the industry. Here are some of the specific implications of rescheduling marijuana to Schedule III: •It would make it easier for researchers to study the potential medical benefits of marijuana. •It would make it easier for doctors to prescribe marijuana to patients with certain conditions. •It would make it possible for banks to offer services to marijuana businesses. •It would make it easier for people who use marijuana to obtain housing and employment. •It would have limited implications for state recreational marijuana programs and those who use marijuana recreationally. The decision of whether or not to reschedule marijuana is a complex one, and there are a number of factors that the DEA will need to consider. However, the HHS's recommendation is a significant step forward and could pave the way for further reforms in the future. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us a text

Has a federal court legalized delta-8 THC with a recent federal court order that temporarily blocked the DEA from enforcing a rule that would have classified delta-8 THC as a controlled substance? The order was issued by a U.S. District Court judge in Washington, D.C., and it is still in effect. However, it is important to note that this is just a temporary order, and it is not yet clear whether the DEA will appeal the decision. If the DEA does appeal the decision, it is possible that the court could ultimately rule that delta-8 THC is a controlled substance. In that case, delta-8 THC would be illegal in all 50 states. Even if the DEA does not appeal the decision, it is still possible that some states could ban delta-8 THC. As of now, only 14 states have banned delta-8 THC, but other states could follow suit. So, the legal status of delta-8 THC is still uncertain. It is possible that it could be legal in all 50 states, but it is also possible that it could be illegal in some or all states. It is important to stay up-to-date on the latest developments in this area. Here are some additional things to keep in mind: The 2018 Farm Bill legalized hemp, which is defined as cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis. Delta-8 THC is a compound that occurs naturally in hemp, but it can also be produced synthetically. The DEA issued a rule in 2020 that would have classified delta-8 THC as a controlled substance. However, the rule was challenged in court, and the federal court order that I mentioned earlier blocked the DEA from enforcing the rule. The legal status of delta-8 THC is still evolving, and it is important to stay up-to-date on the latest developments.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu